StrandPulse Triple 10mg Retatrutide

StrandPulse Triple contains Retatrutide, a novel synthetic peptide designed as a triple-agonist (tri-receptor agonist) that simultaneously targets and activates three key hormone receptors:

– GLP-1 receptor (glucagon-like peptide-1)

– GIP receptor (glucose-dependent insulinotropic polypeptide)

– Glucagon receptor (GCG/GCGR)

This multi-receptor mechanism enables researchers to explore synergistic effects on metabolic pathways, including energy expenditure, glucose homeostasis, appetite regulation, and fat metabolism in controlled experimental settings. Retatrutide is a 39-amino acid peptide sequence conjugated to a C20 fatty diacid moiety for enhanced stability and prolonged half-life (approximately 6 days in pharmacokinetic studies). Supplied as a white lyophilized powder in a sterile 10mg vial, it offers >98-99% purity (verified via HPLC/third-party testing where applicable). Ideal for studies investigating next-generation metabolic modulation beyond dual-agonist compounds.

– Triple-Agonist Innovation: Balanced activation of GLP-1, GIP, and glucagon receptors for comprehensive metabolic pathway investigation (stronger relative potency at GIP receptor).

– High Purity & Quality**: Sourced for research excellence with third-party verification potential; lyophilized for long shelf-life (stable at -20°C or colder for extended periods).

-Convenient Weekly Dosing Profile** (in models): Half-life supports once-weekly experimental administration.

– Premium Research Focus: Designed for studies on obesity mechanisms, glucose control, energy expenditure, and fat loss pathways—shows promise in preclinical/clinical models for substantial effects.

– Coastal-Brand Appeal: StrandPulse branding ties into Grand Strand Supplements’ premium, science-driven wellness ethos.

– Active Peptide: Retatrutide (LY3437943) – 10 mg per vial

– Form: Lyophilized (freeze-dried) powder

– Purity: ≥98-99% (research-grade, batch-specific COA available upon request)

– Excipients/Stabilizers: None added beyond standard lyophilization excipients (e.g., may include trace mannitol or buffers for stability; exact composition varies by synthesis—refer to provided COA)

– Reconstitution Solvent: Not included—typically requires bacteriostatic water or sterile water for injection (research use only)

No additional fillers, preservatives, or human-grade additives are present.

For research and laboratory purposes only.

– Reconstitute the lyophilized powder with an appropriate volume of bacteriostatic water or sterile solvent (e.g., 1-2 mL for desired concentration).

– Store reconstituted solution refrigerated (2-8°C) and use within recommended stability windows (typically days to weeks, depending on protocol).

– Handle under sterile conditions with appropriate lab equipment (syringes, vials, etc.).

– Typical experimental protocols involve subcutaneous or in-vitro administration in model systems to study dose-dependent effects on metabolic parameters.

– Always follow institutional guidelines, GLP standards, and specific study designs. Do not exceed research-appropriate concentrations.

– Research Use Only: Strictly not for human or veterinary use, consumption, injection, or therapeutic application. Not FDA-approved for any medical purpose. Misuse may pose serious health risks.

– Potential Risks in Studies: Known experimental observations include gastrointestinal effects (e.g., nausea analogs in models), increased heart rate, elevated liver enzymes, pancreatitis signals, hypoglycemia risk (especially in glucose-modulating contexts), and other metabolic/organ impacts.

– Handling Precautions: Use personal protective equipment (gloves, eye protection); avoid inhalation, skin contact, or ingestion. Keep out of reach of unauthorized personnel.

– Storage: Sealed, away from light/moisture; refrigerate or freeze lyophilized form. Discard if compromised.

– Legal/Regulatory: Compliance with all local, state, and federal regulations required for research peptides. Not a dietary supplement. Consult qualified professionals for any experimental protocol.